<DOC>
	<DOCNO>NCT01018199</DOCNO>
	<brief_summary>In study investigator aim test C-reactive protein ( CRP ) procalcitonin ( PCT ) - guide strategy allow reduce antibiotic use patient wiht community-acquired pneumonia . Therefore , safety intervention carefully measure .</brief_summary>
	<brief_title>Procalcitonin Versus C-reactive Protein Guide Therapy Community Acquired Pneumonia</brief_title>
	<detailed_description>Methods • Patients setting : All adult ( &gt; 18 year old ) patient diagnosis community-acquired pneumonia receive initial antibiotic therapy base local guideline susceptibility pattern , accord decision treating physician.Patients randomly assign one two group , respectively include PCR PCT clinical procedure protocol . Randomization do use table random number generate computer . For practical reason doctor treat patient question science group patient include . Patients include two group baseline assessment first day study : - Clinical evaluation basic - Start antibiotic therapy - Inclusion study - Randomization ( sign Informed Consent ) - Interventions : They circulate PCT CRP level measure baseline day 1,2,3 e 5 group . Group 1 - CRP group : duration antibiotic therapy base circulate CRP level . Group 2 - PCT group : duration antibiotic therapy base circulate PCT level . Patients enrol study undergo daily measurement plasma CRP ( Dry Chemistry - Johnsons &amp; Johnsons ) PCT ( BRAHMS PCT VIDAS ) level day 5 , , every 48hr patient remain ICU , every 5 day transfer ward . Patients follow 28 day , death hospital transference , come first . PCT CRP result release sealed envelope . During study period , result correspond patient randomization group open ; i.e. , CRP CRP group patient PCT PCT group patient . Criteria antibiotic interruption : The investigator propose interruption antibiotic : 1 . The patient clinically stable , without sign active infection 2 . CRP group : relative reduction 50 % baseline CRP level , value lower 25mg/dl reach . 3 . PCT group : relative reduction 90 % baseline PCT level , absolute value low 0.1 ng/ml reach . The final decision regard antibiotic therapy always let discretion treat physician .</detailed_description>
	<mesh_term>Pneumonia</mesh_term>
	<mesh_term>Anti-Bacterial Agents</mesh_term>
	<mesh_term>Antibiotics , Antitubercular</mesh_term>
	<criteria>1 . Age ≥ 18 year 2 . Signed informed consent 3 . Suspected confirm communityacquired pneumonia 1 . Nosocomial pneumonia : development symptom 48 hour admission Emergency Department , within 14 day hospital discharge 2 . Patients lung cancer confirm strongly suspect . 3 . Patients severe immunosuppression , severe neutropenia ( &lt; 500 neutrófilos/mm3 ) , use corticosteroid dose 0.5 mg / kg / day prednisone equivalent least 2 week , transplantation solid organ cell hematopoietic , use immunosuppressant reason ( eg . azathioprine cyclosporine ) , hipogamagloulinemia 4 . Patients asplenia order 5 . Pregnant 6 . Patients know HIV infection 7 . Stay indicated social reason 8 . Patients antibiotic reason 9 . Patients multiple trauma , burn surgery grid size last 5 day</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2012</verification_date>
	<keyword>C-reactive protein</keyword>
	<keyword>procalcitonin</keyword>
	<keyword>community-acquired pneumonia</keyword>
	<keyword>antibiotic therapy</keyword>
</DOC>